These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25027226)

  • 1. Tuberculosis screening in a dialysis unit: detecting latent tuberculosis infection is only half the problem.
    Brij SO; Beck SC; Kleemann F; Jack AL; Wilkinson C; Enoch DA
    J Hosp Infect; 2014 Aug; 87(4):241-4. PubMed ID: 25027226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
    Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.
    Shu CC; Hsu CL; Lee CY; Wang JY; Wu VC; Yang FJ; Wang JT; Yu CJ; Lee LN
    PLoS One; 2015; 10(4):e0124104. PubMed ID: 25919813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening contacts for latent tuberculosis infection (LTBI) using an interferon test in Paris in 2009].
    Fournier A; Antoun F; Collignon A; Muller G; Rouvier J; Ayache B; Guesnon MS; Larnaudie S
    Rev Mal Respir; 2012 Jan; 29(1):28-39. PubMed ID: 22240217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single and dual latent tuberculosis screening strategies before biologic and targeted therapy in patients with rheumatic diseases: a retrospective cohort study.
    Tang I; So H; Luk L; Wong V; Pang S; Lao V; Yip R
    Hong Kong Med J; 2020 Apr; 26(2):111-119. PubMed ID: 32245912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
    Saunders MJ; Koh GC; Small AD; Dedicoat M
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
    Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
    Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.
    Schwartz IS; Bach PJ; Roscoe B; Majury A; Hopman WM; Ellis E; Garrahan T; Smith J; Barkley R; Panaro L; Jamieson F; Froats C; Gemmill I; Wobeser WL
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):787-92. PubMed ID: 24902553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort.
    Kim HW; Min J; Choi JY; Shin AY; Myong JP; Lee Y; Yim HW; Jeong H; Bae S; Shim E; In H; Chun C; Kim G; Kang JY; Lee SS; Park JS; Kim JS
    J Korean Med Sci; 2021 Sep; 36(36):e246. PubMed ID: 34519187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional Adequacy and Latent Tuberculosis Infection in End-Stage Renal Disease Patients.
    Baek SD; Jeung S; Kang JY
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31561559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial T-SPOT.TB and quantiFERON-TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection.
    Chiappini E; Bonsignori F; Mangone G; Galli L; Mazzantini R; Sollai S; Azzari C; de Martino M
    Pediatr Infect Dis J; 2012 Sep; 31(9):974-7. PubMed ID: 22572749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].
    Knappik M; Schönfeld N; Günther A; Bergmann T; Magdorf K; Rüssmann H; Mauch H; Barker M
    Pneumologie; 2012 Apr; 66(4):207-11. PubMed ID: 22477480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.